Antigoni Triantafyllopoulou, M.D., and Peter Barland, M.D.

Dr. Triantafyllopoulou is Senior Resident, Department of Medicine, Montefiore Medical Center and Albert Einstein College of Medicine, New York.

Dr. Triantafyllopoulou reports no commerical conflicts of interest.

Release Date: 03/21/2005
Termination Date: 03/21/2008

Estimated time to complete: 1 hour(s).

Albert Einstein College of Medicine designates this enduring material for a maximum of 1 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Albert Einstein College of Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
Upon completion of this Cyberounds^®, the participant should be able to:

• Describe the glandular and systemic manifestations of primary Sjogren's syndrome
• Differentiate primary Sjogren's syndrome from other diseases that cause sialadenitis and keratoconjunctivitis (dry mouth and dry eyes)
• Identify the prognostic factors that may produce increased mortality in patients with primary Sjogren's syndrome
• Describe the clinical and laboratory criteria needed to make a diagnosis of primary or secondary Sjogren's syndrome
• Discuss the current therapeutic modalities for the management of patients with Sjogren's syndrome.

 

This conference may include discussion of commercial products and services.

The opinions expressed herein are those of the authors and do not necessarily represent the views of the sponsor or its publisher. Please review complete prescribing information of specific drugs or combination of drugs, including indications, contraindications, warnings and adverse effects before administering pharmacologic therapy to patients.

 

Please click below to accept the terms of this CME activity